{"title": "PDF", "author": "PDF", "url": "https://europepmc.org/articles/pmc2555377/pdf/bullwho00330-0012.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "oftherepeated injections ofchildren Fourfold andgreaterType increase inantibodyaccine used of virus Total Negative Total_% Monovaccine 1 227 148 143 97(once)2 81 68 68 100 3 89 68 65 96 Divaccine 2 150 70 57 81(once)3 150 55 44 80 Trivaccine 1 189 102 70 69(once)2 189 129 97 75 3 189 144 66 46 Trivaccine 1 141 84 76 90(twice)2 141 82 81 99 3 141 108 82 76 Trivaccine 1 141 84 84 100(3times)2 141 82 82 100 3 141 108 94 87 Monovaccine oftypeI+divaccine 1 860 360 283 79oftypes2&3a2 860 510 463 91 3 860 432 312 72 Monovaccine oftype1+divaccine 1 860 360 352 98oftypes2&3+trivaccine a2 860 510 507 99 3 860 432 aSubjects selected atrandom. IN1959 POLIOMYELITIS VACCINATION CAMPAIGN INUSSR Region Age-group Vaccinated Internal control External control(years) group wLO 1to)axCDcs CCY) coC4 CC 1 0) OrCLO co CD C C IU--LO1- 00 * 1 COI CO CO C) CDO1, - CC) 00 CC) q CO D I CCO I C) C:O 0 0 r- CO F 04 d CO 0_ -J .0.. 0F.) 00 0cco .0 00 0)CL n az0 m on FC 04 1 LC Ch Co 6z S?. 0Z 00 0 a) 0 0) COcg0 COLOC4_04001LO LOCC) 04CO0)rOX 0a 0 Ca 0 t C O CO CO CO I 0 0 _ Co c400oaCQCOO4OCO_- aaN t cO M00C,,COco 04 40 o_ 0713 a 4._ o DaC a c Qa a. C,, 0 0 - D 0 a CD .- a- Q) -4 0 0 C. 0 (0J 0 z d z Wz:3CC Z0 Beforevaccination Aftervaccination Age-group Percentage without antibody to Percentage to(years) No. poliovirus type: No. 0 poliovirus type: examined 1 2 3 All examined 1 2 3 All 0-2 55 60 65 65 36 60 20 13 20 0 3-4 22 45 54 50 22 11 10 0 9 9 5-6 15 40 53 26 0 30 0 0 6 0 7-9 45 31 37 38 13 27 4 15 22 4 10-12 48 35 50 27 20 43 12 14 16 0 13-15 35 28 31 17 0 29 10 3 3 0 Total 220 200 TABLE 6.SUSCEPTIBILITY TOPOLIOMYELITIS OFCHILD POPULATION Beforevaccination Aftervaccination Age-group Percentage without antibody to poliovirus type: No. poliovirus type:examined t1 2|_3_ All examined 1 213 All 0-2 67 64 78 66 41 33 0 10 3 0 3-4 45 42 50 35 20 30 10 13 13 0 5-6 44 25 41 23 6 41 10 5 22 0 7-9 72 25 39 29 4 67 2 1 12 0 10-12 43 19 34 27 0 84 2 5 14 0 13-15 25 16 22 4 0 78 1 1 5 0 16-20 22 18 18 10 0 56 10 6 16 0 Total 318 |389 TABLE 7.SUSCEPTIBILITY TOPOLIOMYELITIS Age-group Percentage without antibody to No. poliovirus type: No. poliovirus type:examined 1 examined %-2 138 57 72 59 28 91 14 18 33 0 3-6 107 22 28 32 7 104 5 4 14 1 7-9 81 20 23 25 5 148 3 1 3 0 10-14 95 16 19 22 3 121 1 0 0 0 15-18 84 10 15 17 2 80 6 4 3 0 Total 505 544EFFECTIVENESS OFLIVEPOLIOMYELITIS VACCINE wasnoincrease in thenumber recorded 2 B 61232 B L M 100*4 a 28060 161 148 16 62 Ifcaesa recorded. as internal (118437persons, equivalent to aboutone-third ofthevaccinated group), there wereninecasesofparalytic poliomyelitis-a significant inmorbidity. theunvaccinated groups forming 1957 1958 1959 % PSKOVREGION %100 _ 8076so~~~~~~~~~~8 60 60 % NOVGOROD REGION 10100 ___ __ 60 60 40 40 40 0 049 14 LU 'Wa)7-- DI O -1 lU 0 Lu 0 zEn 0 01- CY r-0CD inm I0D InU) 0 Ic- z 0 w z z z U) 0-Jw,0 z Ul) w- 0 0~-i 0 a. 0 zLuC] 0 U) -J zEFFECTIVENESS Il 0 0 C ._ > - I coa(:OInO cm I, II I _ r-0T- UIcoco In (i)Li-.. a 0 -a 0 -i as >0 >Co 04 Co 04 00 It O0Il- 20 0) coC._ (a a 0l I- III I IoJC4 04 I I _ II 40 ciUiCOCIACMLO r- 04WIWo~~~~~~v CO -a I- -O z0) LO~U. z 0 z >Ul U) z > I-- -i "}